Fredrika Killander

6PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersTumour immunologyRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 30, 2026
Investigation of a prostate cancer radiation response signature in the breast cancer SweBCG91RT randomized trial.

|Nov 10, 2025
Stand-alone Transcriptional Immune Response Prediction in Primary Triple-Negative Breast Cancer.

Suze Roostee, Fredrika Killander, Hani Saghir

|Feb 05, 2025
Endothelial Cell pY397-FAK Expression Predicts the Risk of Breast Cancer Recurrences after Radiotherapy in the SweBCG91-RT Cohort.

Rebecca J G Drake, Amalia H Landén, Erik Holmberg

|Apr 18, 2023
Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial.

Axel Stenmark Tullberg, Martin Sjöström, Emma Niméus

|Mar 28, 2023
Low levels of WRAP53 predict decreased efficacy of radiotherapy and are prognostic for local recurrence and death from breast cancer: a long-term follow-up of the SweBCG91RT randomized trial.

Moa Egelberg, Tommaso De Marchi, Gyula Pekar

|Feb 10, 2022
Breast cancer hypoxia in relation to prognosis and benefit from radiotherapy after breast-conserving surgery in a large, randomised trial with long-term follow-up.

Julia Tutzauer, Martin Sjöström, Erik Holmberg

Pageof 1

Frequent Collaborators

5 joint publications

Erik Holmberg

5 joint publications

Per Karlsson

5 joint publications

Emma Niméus

3 joint publications

Martin Sjöström